We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Oxygen Therapy Fails to Prevent Heart Failure in MI Patients

By HospiMedica International staff writers
Posted on 05 Sep 2018
Print article
Oxygen therapy does not prevent the development of heart failure (HF) or reduce long-term risk mortality in patients with a suspected heart attack, according to a new study.

Researchers at Karolinska Institutet (KI; Solna, Sweden), Uppsala University (UU; Sweden), Lund University (LU; Sweden), and other institutions conducted a study in 6,629 patients with suspected acute myocardial infarction (MI) treated at 35 Swedish hospitals. Patients with oxygen saturation of 90% or over were randomly assigned to receive either supplemental oxygen at 6 L/min for 6-12 hours delivered by open face mask, or ambient air. The primary outcomes were survival benefit at one year, cardiovascular death, and a composite of all-cause death and hospitalization for HF.

The results revealed that all-cause death or hospitalization for HF within one year occurred in 8% of the patients assigned to oxygen, and in 7.9% of patients assigned to ambient air. During long-term follow-up, the composite end point occurred in 11.2% of patients assigned to oxygen and in 10.8% of patients assigned to ambient air, and cardiovascular death occurred in 5.2% of patients assigned to oxygen and in 4.8% assigned to ambient air. Results were consistent across all predefined subgroups. The study was published on August 26, 2018, in Circulation.

“Our new study has filled a central gap in knowledge regarding how to treat patients suffering a heart attack. Oxygen therapy does not reduce the development of heart failure, the most worrying complication of heart attacks,” said corresponding author consultant cardiologist Robin Hofmann, MD, of the Karolinska Institutet. “On this basis, the routine use of oxygen can now be eliminated, and healthcare personnel can concentrate on more efficient measures and rapid transport to hospital.”

Oxygen has been used to treat patients suffering a heart attack for more than a century, despite the fact that such treatment has not had any scientifically proven effect on patients who have normal oxygen saturation levels in their blood. Since the turn of the millennium, researchers worldwide have started to question whether oxygen therapy for heart attacks is ineffective, or may even be harmful.

Related Links:
Karolinska Institutet
Uppsala University
Lund University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscopy Head Support
Reison 10-330

Print article

Channels

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more